Hemostasis & Tissue Sealing Agents Market Growth & Forecast 2024-2031

by Newsroom


(Medical-NewsWire.com, March 25, 2025 ) Market Overview

Hemostasis & Tissue Sealing Agents Market is expected to grow at a CAGR of 8.3% in the forecast period (2024-2031).

Download Free Sample:
rnhttps://www.datamintelligence.com/download-sample/hemostasis-tissue-sealing-agents-market
Market Dynamics

The global hemostasis and tissue sealing agents market is driven by the increasing number of surgeries and demand for minimally invasive procedures. Hemostatic agents are preferred in complex surgeries like cardiovascular and endoscopic procedures due to faster recovery and effectiveness in sensitive organs. Rising trauma cases and hemorrhage-related deaths further boost demand. According to the U.S. National Library of Medicine, over 3,792 clinical studies on hemorrhage conditions are ongoing globally. However, limited reimbursement policies may hinder market growth.

Market Segment

By Product Type: Hemostats, Mechanical, Active, Flowable, Sealants, Fibrin sealants, Synthetic sealants, Adhesives, Cyanoacrylate, Albumin, Glutaraldehyde
By Therapeutic Area: Cardiovascular, Ophthalmology, Gynecology, Urology, Dental, Orthopedic, Others
By Class: Fibrin, Collagen, Cellulose, Thrombin, Gelatin, Others

Request for Customization:
rnhttps://www.datamintelligence.com/customize/hemostasis-tissue-sealing-agents-market

Market Geographical Share

North America leads the hemostasis & tissue sealing agents market due to the high prevalence of chronic diseases requiring surgery. In the U.S., 60% of adults have a chronic disease, with 40% having two or more. Europe also holds a significant share, driven by advanced sealing agents like Tectum, launched in 2018 by Lobachevsky University. Baxter International introduced FLOSEAL FSP in 2017, initially in Europe before global distribution began in 2019.

Market Key Players

Pfizer Inc., Johnson & Johnson, Cohera Medical, Medafor, Zimmer Biomet, King Pharmaceuticals Inc., ZymoGenetics, Baxter Healthcare Corporation, CryoLife, Integra LifeSciences Corporation, and B. Braun.

DataM Intelligence
Sai Kiran
+1 877 441 4866
pr@datamintelligence.com

Source: EmailWire.Com



Source link

Related Posts

aBOUT uS

About Medical Newswire™ aggregates, publishes and distributes news about the medical industry. In association with EmailWire, Medical Newswire™ provides press release distribution services in the medical sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us at these messaging apps:

Mobile/WhatsApp: +1832-716-2363
Skype: groupwebmedia
Telegram: @groupwebmedia

rECENT nEWS

Medical Newswire™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC